• AA
  • Share

Brave New World: Introducing the Journal of the Endocrine Society

The Endocrine Society is launching its first Open Access journal and its first new journal in over 30 years.

The Endocrine Society will expand its publication offerings to authors and readers with an Open Access (OA) journal to begin publishing in fall 2016.

The new journal, the Journal of the Endocrine Society (JES) — will be led by editor-in-chief and Society Past-President Larry Jameson, MD, PhD, executive vice president of the University of Pennsylvania for the Health System and dean of the Perelman School of Medicine at the University of Pennsylvania, along with a team of associate editors currently being assembled. In-house, newly hired executive editor Timothy Beardsley, PhD, will manage the journal’s day-to-day operations.

As the inaugural editor-in-chief, Jameson is excited by the prospects that new endocrinology discoveries will be available as quickly as possible after peer review and editorial assessment. He adds that the open-access format will allow research articles, case reports, images, and other features of interest to be available to readers worldwide, “fulfilling a goal to provide ready access to high-quality information for all physicians, scientists, students, and the public.”

JES will publish top-quality research in all areas of basic, translational, and clinical endocrinology. The journal will provide rapid peer-review and continuous online publication of accepted edited articles for citation, indexing, and discoverability. Scope will include research articles as well as reports, mini-reviews, commentaries, tools and methods, datasets, and other contributions that advance the field of endocrinology.

The OA format of JES will make it possible for the Society to publish high-quality scientific research papers without being restricted by the page limitations of a print journal. The new journal will create the opportunity for more scientists to publish their work and offer an avenue for cutting-edge research to advance science and improve medical care.

“Open Access publishing gives the public free global access to peer-reviewed content online,” says Richard O’Grady, PhD, the Society’s Chief Publications Officer. “It gives authors’ work increased speed to publication, exposure and discoverability, and compliance with relevant grant rules.”

Sign up for updates about the new OA journal at www.endocrine.org/jesopenaccess.

Q&A with Larry Jameson, MD, PhD

If you attended ENDO 2016 in Boston last month, then you know that the excitement surrounding the launch of the Journal of the Endocrine Society (JES) was one of the major revelations this year, aside from the remarkable scientific content presented.

To mark this momentous event and to give JES the gravitas it deserves, J. Larry Jameson, MD, PhD, will serve as the inaugural editor-in-chief of this new journal. Jameson became executive vice president of the University of Pennsylvania for the Health System and dean of the Raymond and Ruth Perelman School of Medicine in 2011. Prior to that he was dean of the Feinberg School of Medicine and vice president of Medical Affairs at Northwestern University since 2007.  He joined Northwestern University Medical School in 1993 as chief of the Division of Endocrinology, Metabolism, and Molecular Medicine, a position he held for seven years. In 2000, he was named Irving S. Cutter Professor of Medicine and chair of the Department of Medicine.

He received his medical degree with honors and a doctoral degree in biochemistry from the University of North Carolina in 1981. He completed clinical training in internal medicine and endocrinology at Massachusetts General Hospital in Boston. Before leaving for Northwestern University, he rose through the ranks at Harvard Medical School to become an associate professor of medicine and chief of the Thyroid Unit at Massachusetts General Hospital.

A prolific physician-scientist and writer, Jameson has been a pioneer in molecular medicine in the field of endocrinology. His research has focused on the genetic basis of hormonal disorders and he is the author of more than 300 scientific articles and chapters. His work has been published in leading peer-reviewed journals and he is an editor of Harrison’s Principles of Internal Medicine, the most widely used medical text worldwide, and co-editor of Jameson and DeGroot’s Endocrinology, now in its sixth edition.

Jameson took time out of his busy schedule to discuss his new role – among many, many roles in the world of endocrinology – as the editor-in-chief of JES, and what he hopes to accomplish, not just for the journal and the Endocrine Society, but for the field of endocrinology both here and around the world.

Endocrine News: Why is it important for the Endocrine Society to have an Open Access journal?

Larry Jameson: Open Access is a new, and I believe important, model for disseminating information. The Endocrine Society has always been a leader in publishing in the field of endocrinology. The Journal of the Endocrine Society will be the Society’s first new journal in more than 30 years. OA means that anyone with access to the Internet can read papers in JES. This not only provides greater equity across the globe but also ensures that our author’s papers will have a larger audience and likely citations.

“I want to support endocrinologists and scientists interested in hormone physiology and clinical care by providing a top-tier outlet for their scholarly work, to be read and cited by physicians, trainees, and the lay public worldwide.”

EN: How will the Journal of the Endocrine Society’s content differ from the content in the other Society journals?

LJ: JES will publish the full range of content in the field of endocrinology, including basic science and clinical endocrinology, mirroring the interests of our membership. The OA format, being entirely online, creates flexibility in the types of publications, as well as the number of publications. For example, in addition to original research, case reports, mini-reviews, editorials, and Society position papers, we plan to publish images, databases, and create interactive media.

“I am deeply committed to the mission and success of the Endocrine Society, which I consider my home as a professional organization.”

EN: What intrigued you about becoming the editor-in-chief of JES?

LJ: Three main features intrigued me about launching JES as its inaugural editor-in-chief: 1. Like all of our members, I am deeply committed to the mission and success of the Endocrine Society, which I consider my home as a professional organization; 2. I believe JES will serve as a great equalizer in terms of access to high-quality information worldwide; 3. Having served in other editorial capacities for textbooks and journals, I am eager to engage in the new OA model of publishing. I am confident that JES will be very successful and perhaps pave the way for the evolution of other Society journals.

EN: What are your overall goals for JES?

LJ: First, I am assembling a renowned group of associate editors (AEs) with a broad international footprint and range of interests within domains of endocrinology. This international group of AEs will attract a broader base of submissions and reviewers. Second, I want to ensure that JES sets high standards for peer review and its accepted papers, consistent with the values of the Endocrine Society for all of its publications and meetings. Third, I want to support endocrinologists and scientists interested in hormone physiology and clinical care by providing a top-tier outlet for their scholarly work, to be read and cited by physicians, trainees, and the lay public worldwide. Fourth, I want to shorten the time for review and publication; and finally, to expand knowledge and improve health by ensuring broad access to discoveries, evidence, and best practices in endocrinology.

***

Throughout his storied career, Jameson has received many distinguished awards, including the Van Meter Award from the American Thyroid Association and the Sheen Award from the American College of Surgeons. The Endocrine Society has honored him with the Ernst Oppenheimer Award, presented to a young investigator in recognition of meritorious accomplishments in basic or clinical endocrinology, and the Fred Conrad Koch Award, considered the highest honor bestowed by the Society in recognition of exceptional contributions to the field.

“The Endocrine Society has always been at the forefront of disseminating knowledge in our field,” Jameson adds. “The launch of the new open access journal is only the latest example of how the Society continues to support the needs and interests of endocrinologists worldwide.”

You may also like

  • Endocrine Society Response to Immigration Order

    President Donald Trump signed an executive order on Friday, January 27, limiting refugees into the U.S., barring the citizens of seven countries – Iraq, Iran, Syria, Somalia, Sudan, Libya, and Yemen – from entering the U.S. on any visa category, and, consequently, also creating new barriers to the global exchange of scientific information. The order…

  • Rare Endocrine Diseases Highlighted in New Awareness Campaign

    A new global campaign has been launched by Alexion Pharmaceuticals, Inc., to raise awareness of bone disorder hypophosphatasia (HPP), metabolic disease lysosomal acid lipase deficiency (LAL-D), and other rare diseases. Uncommon Strength celebrates the extraordinary resilience and inner strength of individuals impacted by these diseases, according to a company statement. Aside from HPP and LAL-D, the…